HSD11B2

HSD11B2

Target · Steroid-metabolising enzyme

HSD11B2 Hydroxysteroid 11-beta dehydrogenase 2 · 11-beta-hydroxysteroid dehydrogenase type 2

HSD11B2 (hydroxysteroid 11-beta dehydrogenase 2, also known as SDR9C3) is an NAD(+)-dependent microsomal enzyme that inactivates cortisol by converting it to cortisone. By lowering local active glucocorticoid levels, it protects the mineralocorticoid receptor from inappropriate activation. Browse Assay Genie's current range of HSD11B2 research reagents below, or read on for the biology behind the target.

Endoplasmic reticulum microsomeNAD(+)-dependent dehydrogenaseProtects mineralocorticoid receptor
405 aa
Protein length
~44 kDa
Molecular weight
16q22.1
Gene locus
EC 1.1.1.-
Enzyme class
Target information

What is HSD11B2 (hydroxysteroid 11-beta dehydrogenase 2)?

HSD11B2 catalyses the conversion of biologically active 11beta-hydroxyglucocorticoids, such as cortisol, to inactive 11-ketoglucocorticoids, such as cortisone, in the presence of NAD(+). It acts as a dehydrogenase (oxidase) only, thereby decreasing the concentration of active glucocorticoids and protecting the nonselective mineralocorticoid receptor from occupation by glucocorticoids. In aldosterone-selective epithelial tissues such as the kidney, this prevents illicit activation of the receptor. In tissues that do not express the mineralocorticoid receptor, such as the placenta and testis, it protects cells from the growth-inhibiting and pro-apoptotic effects of cortisol, particularly during embryonic development.

The enzyme also acts on other substrates. It oxidises 11beta-hydroxytestosterone to 11-ketotestosterone, a major bioactive androgen, and converts 11beta-hydroxyandrostenedione to 11-ketoandrostenedione, which can be further metabolised to 11-ketotestosterone. In vitro it converts 7-beta-25-dihydroxycholesterol to 7-oxo-25-hydroxycholesterol; the former, but not the latter, is a ligand for the GPCR EBI2 and may thereby regulate immune cell migration. It also converts 7-beta-hydroxycholesterol to 7-ketocholesterol, a precursor of 7-keto,27-hydroxycholesterol, which activates smoothened and the smoothened signalling pathway. Further roles include maintaining glucocorticoid balance during preimplantation, protecting the fetus from excess maternal corticosterone, and possibly protecting ovulating oocytes and fertilising spermatozoa from cortisol.

The HSD11B2 gene encodes a member of the short-chain dehydrogenase/reductase (SDR) family, found in microsomes of the endoplasmic reticulum. It is the type II isozyme of corticosteroid 11-beta-dehydrogenase. The type I isozyme, HSD11B1, has both 11-beta-dehydrogenase and 11-oxoreductase activities, whereas the type II enzyme has only dehydrogenase activity. Mutations in this gene cause the syndrome of apparent mineralocorticoid excess and hypertension. Mouse and rat orthologs are both named Hsd11b2.

Glucocorticoid metabolism

HSD11B2 inactivates cortisol to cortisone, so it is central to studies of local glucocorticoid availability in tissues.

Mineralocorticoid receptor signalling

By preventing glucocorticoid occupation of the mineralocorticoid receptor, the enzyme supports aldosterone-selective signalling in epithelial tissues such as the kidney.

Hypertension research

Mutations in HSD11B2 cause apparent mineralocorticoid excess with hypertension, making it a reference target for this syndrome.

Placental and reproductive biology

The enzyme protects the fetus from maternal corticosterone and shields placental and testicular cells from cortisol-induced growth inhibition and apoptosis.

Background

HSD11B2 frequently asked questions

What does HSD11B2 do?

HSD11B2 oxidises active 11beta-hydroxyglucocorticoids such as cortisol to inactive cortisone, using NAD(+). This lowers active glucocorticoid levels and protects the mineralocorticoid receptor from occupation by glucocorticoids, particularly in the kidney. It also acts on 11beta-hydroxytestosterone and certain oxysterols.

What other names are used for HSD11B2?

The HGNC name is hydroxysteroid 11-beta dehydrogenase 2, previously hydroxysteroid (11-beta) dehydrogenase 2, and the symbol SDR9C3 is an alias. UniProt calls the protein 11-beta-hydroxysteroid dehydrogenase type 2. It is the type II isozyme of corticosteroid 11-beta-dehydrogenase, distinct from type I (HSD11B1).

Is HSD11B2 linked to disease and conserved in rodents?

Mutations in the HSD11B2 gene cause the syndrome of apparent mineralocorticoid excess and hypertension. Orthologs exist in mouse and rat, both designated Hsd11b2, so rodent models are used to study the enzyme. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other hydroxysteroid dehydrogenases and short-chain dehydrogenase/reductase family members involved in steroid metabolism.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P80365; product specifications from Assay Genie datasheets.

HSD11B2 Product listing